Singapore-based private equity and VC firm Heritas Capital aims to make the initial close of its second fund in the first half of 2021, as per multiple reports.
Launched in December 2020 with a target fund size of US$30 million, Heritas Venture Fund II (HVF II) plans to invest in up to 15 seed and Series A-stage companies in sectors ranging from foodtech to edtech across Asia.
The development comes at a time when verticals such as online learning and alternative food markets are seeing accelerated growth, thanks to COVID-19.
“We are seeing a strong pipeline of attractive deal flows, which are also impactful in terms of enhancing access to affordable quality healthcare and education, and contributing to sustainable growth,” said Chik Wai Chiew, CEO and Executive Director of Heritas Capital.
Heritas recently led a US$3 million Series A+ funding round in Cakap, an Indonesian online language learning platform. Its other portfolio companies include Indonesian telehealth startup Alodokter and Singapore-based mental health firm Holmusk.
Also Read: Cakap bags US$3M in Series A+ funding to expand its language learning platform in Indonesia
Launched in 2017, Heritas Capital has so far invested in 10 startups, including biotech platform Hummingbird Bioscience and foodtech startup Alchemy Foodtech, which specialises in food innovations to fight diabetes and other chronic diseases.
According to reports, the investment firm has plans to launch another PE fund, Termed Heritas Growth Fund III, with a corpus of US$150 million.
—
Image Credit: Photo by Peter Nguyen on Unsplash
The post Heritas Capital aims to hit initial close of US$30M fund II in H1 2021 appeared first on e27.